CIK 0001901440 · Large accelerated filer
UL Solutions Inc.
Sign in to watch- Ticker
- ULS
- Exchange
- NYSE
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270913800
- Phone
- (847) 272-8800
- Business address
- 333 PFINGSTEN ROAD, NORTHBROOK, IL, 60062
- Former names
- UL Solutions Inc., UL Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,734,738
- in 3 filings, $2.7M under 10b5-1 plans
Net −$2,734,738. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-01 | Uggetti Alberto EVP & CCO | Shares withheld for taxes | −223 | $83.80 | $19K | 13,551 |
| 2026-04-01 | Uggetti Alberto EVP & CCO | Grant or award | +2,608 | $83.80 | $219K | 16,159 |
| 2026-04-01 | Uggetti Alberto EVP & CCO | Shares withheld for taxes | −616 | $83.80 | $52K | 15,543 |
| 2026-04-01 | Uggetti Alberto EVP & CCO | Option exercise · Restricted Stock Units | −944 | 1,890 | ||
| 2026-04-01 | Uggetti Alberto EVP & CCO | Grant or award · Restricted Stock Units | +2,287 | 2,287 | ||
| 2026-04-01 | Schjotz Gitte See Remarks | Option exercise | +1,643 | 61,451 | ||
| 2026-04-01 | Schjotz Gitte See Remarks | Grant or award | +9,045 | $84.57 | $765K | 70,496 |
| 2026-04-01 | Schjotz Gitte See Remarks | Option exercise · Restricted Stock Units | −1,643 | 3,288 | ||
| 2026-04-01 | Schjotz Gitte See Remarks | Grant or award · Restricted Stock Units | +3,941 | 3,941 | ||
| 2026-04-01 | Scanlon Jennifer F. President and CEO | Option exercise 10b5-1 | +14,265 | 186,128 | ||
| 2026-04-01 | Scanlon Jennifer F. President and CEO | Shares withheld for taxes 10b5-1 | −6,320 | $84.57 | $534K | 179,808 |
| 2026-04-01 | Scanlon Jennifer F. President and CEO | Grant or award 10b5-1 | +60,084 | $84.57 | $5.1M | 239,892 |
| 2026-04-01 | Scanlon Jennifer F. President and CEO | Shares withheld for taxes 10b5-1 | −26,618 | $84.57 | $2.3M | 213,274 |
| 2026-04-01 | Scanlon Jennifer F. President and CEO | Sale 10b5-1 | −4,923 | $84.98 | $418K | 208,351 |
| 2026-04-01 | Scanlon Jennifer F. President and CEO | Sale 10b5-1 | −7,577 | $85.84 | $650K | 200,774 |
| 2026-04-01 | Scanlon Jennifer F. President and CEO | Option exercise · Restricted Stock Units 10b5-1 | −14,265 | 28,534 | ||
| 2026-04-01 | Scanlon Jennifer F. President and CEO | Grant or award · Restricted Stock Units 10b5-1 | +36,455 | 36,455 | ||
| 2026-04-01 | Robinson Ryan D Executive VP & CFO | Option exercise | +3,092 | 21,014 | ||
| 2026-04-01 | Robinson Ryan D Executive VP & CFO | Shares withheld for taxes | −1,370 | $84.57 | $116K | 19,644 |
| 2026-04-01 | Robinson Ryan D Executive VP & CFO | Grant or award | +14,213 | $84.57 | $1.2M | 33,857 |
Page 11 of 24 · 474 trades